Discontinued — last reported Q3 '23
Year-over-year, this metric declined by 100.0%, from $151.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -37.6% CAGR.
High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.
This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...
Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $251.00M | $251.00M | $251.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $17.00M | $23.00M | $508.00M | $7.00M | $2.00M | $151.00M | $1.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | — | — | — | — | — | — | +35.3% | >999% | -98.6% | -71.4% | >999% | -99.3% | -100.0% | — | — |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | — | — | — | — | — | — | — | -88.2% | +556.5% | -99.8% | -100.0% | -100.0% | -100.0% |